Рубрики Mesh:
Взрослые
Пожилые
Цистит - осложнения
Цистит - лекарственная терапия
Лекарственная терапия комбинированная
Женский
Человек
Средний возраст
Фитотерапия
Растений экстракты - терапевтическое применение
Мочевых путей инфекции - осложнения
Мочевых путей инфекции - лекарственная терапия
Уролитиаз - этиология
Уролитиаз - профилактика и контроль
Молодые
Журнальная статья
Saenko V.S.
Kapsargin F.P.
Pesegov S.V.
V.
I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Department of Urology, University Clinic of Urology 2, R.M. Fronshteyn Urology Clinic, Moscow, Russia.
Voino-Yasenetsky Krasnoyarsk State Medical University, Department of Urology, Andrology and Sexology, IPE, Krasnoyarsk, Russia.
Troyakov. Experience in using hytolysin in the integrated management of urinary tract infections and methapylactics of nephrolithiasis
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 3 С. 16-21
2017
metaphylaxis
phytotherapy
urinary tract infections
urolithiasis
Статья
Adult M01.060.116
Взрослые M01.060.116
Aged M01.060.116.100
Пожилые M01.060.116.100
Cystitis complications C12.050.351.968.829.495 C12.200.777.829.495 C12.950.829.495
Cystitis drug therapy C12.050.351.968.829.495 C12.200.777.829.495 C12.950.829.495
Цистит осложнения C12.050.351.968.829.495 C12.200.777.829.495 C12.950.829.495
Цистит лекарственная терапия C12.050.351.968.829.495 C12.200.777.829.495 C12.950.829.495
Drug Therapy, Combination E02.319.310
Лекарственная терапия комбинированная E02.319.310
Female
Женский
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Middle Aged M01.060.116.630
Средний возраст M01.060.116.630
Phytotherapy E02.190.755
Фитотерапия E02.190.755
Plant Extracts therapeutic use D20.215.784.500 D26.667
Растений экстракты терапевтическое применение D20.215.784.500 D26.667
Urinary Tract Infections complications C01.915 C12.050.351.968.892
Urinary Tract Infections drug therapy C01.915 C12.050.351.968.892
Мочевых путей инфекции осложнения C01.915 C12.050.351.968.892
Мочевых путей инфекции лекарственная терапия C01.915 C12.050.351.968.892
Urolithiasis etiology C12.050.351.968.967 C12.200.777.967 C12.950.967
Urolithiasis prevention & control C12.050.351.968.967 C12.200.777.967 C12.950.967
Уролитиаз этиология C12.050.351.968.967 C12.200.777.967 C12.950.967
Уролитиаз профилактика и контроль C12.050.351.968.967 C12.200.777.967 C12.950.967
Young Adult M01.060.116.815
Молодые M01.060.116.815
Journal Article V02.600
Журнальная статья V02.600
Urinary tract infection (UTI) are a risk factor for diseases leading to impairment of renal function and kidney stone disease (KSD). Growing resistance of uropathogens to antibacterial agents is a challenging issue in most countries of the world. Urolithiasis is the second most prevalent urologic condition following urinary tract infections and has a pronounced tendency to recur. Rational stone metaphylaxis leads to a significant reduction in the incidence of recurrent stones. In recent decades, there has been a markedly increasing interest in plant-based therapies in managing urologic diseases.